|
1.
|
|
15 p, 802.1 KB |
Combining mindfulness and cognitive training in children with attention deficit hyperactivity disorder : study protocol of a pilot randomized controlled trial (the NeuroMind study)
/
Badia Aguarón, Tania (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Royuela-Colomer, Estíbaliz (Parc Sanitari Sant Joan de Déu) ;
Pera-Guardiola, Vanessa (Sant Joan de Déu Terres de Lleida. Centre de Salut Mental Infantil i Juvenil) ;
Vergés-Balasch, Pere (Sant Joan de Déu Terres de Lleida. Centre de Salut Mental Infantil i Juvenil) ;
Cebolla Marti, Ausias (Universitat de València. Departament de Personalitat, Avaluació i Tractaments Psicològics) ;
Luciano, Juan V. (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Soler, Joaquim (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Feliu-Soler, Albert (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Huguet Miguel, Anna (Sant Joan de Déu Terres de Lleida. Centre de Salut Mental Infantil i Juvenil)
Introduction: Attention Deficit Hyperactivity Disorder (ADHD) has a global mean prevalence of 5%. Cognitive Training (CT) and Mindfulness-Based Interventions (MBIs) have shown promising results in managing ADHD symptoms, but they are not its Treatment-As-Usual (TAU). [...]
2024 -  10.3389/fpsyg.2024.1291198
Frontiers in psychology, Vol. 15 (2024) , art. 1291198
|
|
|
2.
|
|
11 p, 21.0 MB |
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)
/
Tavira, Beatriz (Cancer Center Clínica Universidad de Navarra) ;
Iscar, Teresa (Cancer Center Clínica Universidad de Navarra) ;
Manso, Luis (Hospital 12 de Octubre (Madrid)) ;
Santaballa, Ana (Hospital Universitari i Politècnic La Fe (València)) ;
Gil-Martin, Marta (Institut Català d'Oncologia - Hospital Duran i Reynals) ;
García García, Yolanda (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Romeo, Margarita (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Iglesias, Maria (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
de Juan Ferre, Ana (Hospital Marqués de Valdecilla) ;
Barretina-Ginesta, Maria-Pilar (Institut Català d'Oncologia) ;
Manzano, Aranzazu (Hospital Clínico San Carlos (Madrid)) ;
Gaba, Lydia (Hospital Clínic i Provincial de Barcelona) ;
Rubio, Maria Jesus (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
de Andrea, Carlos E. (Centro de Investigación Biomédica en Red de Cáncer) ;
González-Martín, Antonio (Cancer Center Clínica Universidad de Navarra) ;
Universitat Autònoma de Barcelona
The aim of our study was to elucidate the impact of bevacizumab added to neoadjuvant chemotherapy (NACT) on the tumor immune microenvironment and correlate the changes with the clinical outcome of the patients. [...]
2023 - 10.1158/1078-0432.CCR-23-0771
Clinical Cancer Research, Vol. 30 (august 2023) , p. 176-186
|
|
|
3.
|
|
9 p, 582.7 KB |
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status : a GEICO phase II trial (ROLANDO study)
/
Perez-Fidalgo, J.A. (Hospital Clínic Universitari (València)) ;
Cortés, A. (Hospital Universitario Ramón y Cajal) ;
Guerra, E. (Hospital Universitario Ramón y Cajal) ;
García García, Yolanda (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Iglesias, M. (Hospital Son Llatzer) ;
Bohn Sarmiento, U. (Hospital Universitario de Gran Canaria Doctor Negrín) ;
Calvo García, E. (Hospital Universitario Virgen del Rocío) ;
Manso Sánchez, L. (Hospital Universitario 12 de Octubre) ;
Santaballa, A. (Hospital Universitari i Politècnic La Fe, València) ;
Oaknin, Ana (Hospital Universitari Vall d'Hebron) ;
Redondo, A. (Hospital Universitario La Paz) ;
Rubio, M.J. (Hospital Universitario Reina Sofia) ;
González-Martín, A. (Clínica Universidad de Navarra, Madrid) ;
Universitat Autònoma de Barcelona
There is limited evidence for the benefit of olaparib in platinum-resistant ovarian cancer (PROC) patients with BRCA wild-type tumors. This study investigated whether this combination of a DNA-damaging chemotherapy plus olaparib is effective in PROC regardless BRCA status. [...]
2021 - 10.1016/j.esmoop.2021.100212
ESMO open, Vol. 6 (july 2021)
|
|
|
4.
|
|
8 p, 318.7 KB |
Knowledge, attitudes and preferences among spanish community pharmacists regarding inhaled therapy (The optim pharmacy study)
/
Giner, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Roura Poch, Pere (Hospital General de Vic) ;
Torres, Berta ;
Burgos, Felip (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau) ;
Tarragona, Eduard (Chiesi España) ;
Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
To assess knowledge, attitudes, and preferences regarding inhaled therapy among Spanish community pharmacists. An 11-item questionnaire was developed and distributed to community pharmacists throughout the country. [...]
2016 - 10.22159/ijpps.2016v8i9.11796
International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8 Núm. 9 (2016) , p. 53-60
|
|
|
5.
|
|
19 p, 826.8 KB |
Efficacy of videoconference group acceptance and commitment therapy (ACT) and behavioral activation therapy for depression (BATD) for chronic low back pain (CLBP) plus comorbid depressive symptoms : a randomized controlled trial (IMPACT Study)
/
Sanabria-Mazo, Juan P. (Parc Sanitari Sant Joan de Déu) ;
Colomer-Carbonell, Ariadna (Parc Sanitari Sant Joan de Déu) ;
Borràs, Xavier (Universitat Autònoma de Barcelona) ;
Castaño Asins, Juan Ramon (Hospital del Mar (Barcelona, Catalunya)) ;
McCracken, Lance M (Uppsala Universitet) ;
Montero-Marin, Jesus (Parc Sanitari Sant Joan de Déu) ;
Pérez-Aranda, Adrián (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Edo Izquierdo, Sílvia (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Sanz Ruiz, Antoni (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Feliu-Soler, Albert (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Luciano, Juan V (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut)
This study examined the efficacy of adding a remote, synchronous, group, videoconference-based form of acceptance and commitment therapy (ACT) or behavioral activation therapy for depression (BATD) to treatment-as-usual (TAU) in 234 patients with chronic low back pain (CLBP) plus comorbid depressive symptoms. [...]
2023 - doi.org/10.1016/j.jpain.2023.04.008
The Journal of Pain, Vol. 24 Núm. 8 (2023) , p. 1522-1540
|
|
|
6.
|
|
28 p, 397.3 KB |
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
/
Lam, Thomas B.L. (Aberdeen Royal Infirmary) ;
MacLennan, Steven (University of Aberdeen) ;
Willemse, Peter-Paul M. (University Medical Center Utrecht) ;
Mason, Malcolm D. (Velindre Cancer Centre) ;
Plass, Karin (EAU Guidelines Office) ;
Shepherd, Robert (EAU Guidelines Office) ;
Baanders, Ruud ;
Bangma, Chris H. (Erasmus University Medical Centre) ;
Bjartell, Anders (Lund University) ;
Bossi, Alberto (Gustave Roussy Institute) ;
Briers, Erik ;
Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ;
Buddingh, Karel T. (HagaZiekenhuis) ;
Catto, James W.F. (Royal Hallamshire Hospital) ;
Colecchia, Maurizio (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ;
Cox, Brett W. (Zucker School of Medicine) ;
Cumberbatch, Marcus G. (University of Sheffield) ;
Davies, Jeff ;
Davis, Niall F. (Royal College of Surgeons in Ireland) ;
De Santis, Maria (Charité University Hospital) ;
Dell'Oglio, Paolo (ORSI Academy) ;
Deschamps, André (Europa Uomo) ;
Donaldson, James F. (Aberdeen Royal Infirmary) ;
Egawa, Shin (Jikei University School of Medicine) ;
Fankhauser, Christian D. (University of Zurich) ;
Fanti, Stefano (University of Bologna) ;
Fossati, Nicola (Scientific Institute and University Vita-Salute San Raffaele Hospital) ;
Gandaglia, Giorgio (IRCCS Ospedale San Raffaele) ;
Gillessen, Silke (University of Bern) ;
Grivas, Nikolaos (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Gross, Tobias (University of Bern) ;
Grummet, Jeremy P. (Monash University) ;
Henry, Ann M. (St. James's University Hospital) ;
Ingels, Alexandre (Henri Mondor Hospital) ;
Irani, Jacques (University Hospital of Bicêtre-Paris Sud-Saclay University) ;
Lardas, Michael (Department of Reconstructive Urology and Surgical Andrology) ;
Liew, Matthew (Wigan and Leigh NHS Foundation Trust) ;
Lin, Daniel W. (University of Washington) ;
Moris, Lisa (KU Leuven) ;
Omar, Muhammad Imran (University of Aberdeen) ;
Pang, Karl H. (University of Sheffield) ;
Paterson, Catherine C. (Robert Gordon University) ;
Renard-Penna, Raphaële (Sorbonne Université) ;
Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ;
Roobol, M.J. (Erasmus University Medical Centre) ;
Rouprêt, Morgan (Sorbonne Université) ;
Rouvière, Olivier (Université de Lyon) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Richenberg, Jonathan (Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School) ;
Schoots, Ivo G. (Erasmus University Medical Center) ;
Sedelaar, J.P.Michiel (Radboud University Medical Centre) ;
Stricker, Phillip (Garvan Institute of Research) ;
Tilki, Derya (University Hospital Hamburg-Eppendorf) ;
Vahr Lauridsen, Susanne (Copenhagen University Hospital) ;
van den Bergh, Roderick C.N. (St. Antonius Hospital) ;
Van den Broeck, Thomas (University Hospitals Leuven (Bèlgica)) ;
van der Kwast, Theodorus H. (Erasmus University Medical Center) ;
van der Poel, Henk G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van Leenders, Geert J.L.H. (Erasmus University Medical Center) ;
Varma, Murali (University Hospital of Wales) ;
Violette, Philippe D. (McMaster University (Canadà)) ;
Wallis, Christopher J.D. (Vanderbilt University Medical Center) ;
Wiegel, Thomas (University Hospital of Ulm (Alemanya)) ;
Wilkinson, Karen (University College London Hospitals) ;
Zattoni, Fabio (Academic Medical Centre Hospital) ;
N'Dow, James M.O. (Aberdeen Royal Infirmary) ;
Van Poppel, Hendrik (University Hospitals Leuven (Bèlgica)) ;
Cornford, Philip (Royal Liverpool and Broadgreen Hospitals NHS Trust) ;
Mottet, Nicolas (University Hospital Jean Monnet) ;
Universitat Autònoma de Barcelona
There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. To develop consensus statements for all domains of DAT. [...]
2019 - 10.1016/j.eururo.2019.09.020
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 790-813
|
|
|
7.
|
|
12 p, 1.3 MB |
The Need for the Closer Monitoring of Novel Drugs in MS : A Siponimod Retrospective Cohort Study (Realhes Study)
/
Sancho-López, Arantxa (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Ruiz-Antorán, Belén (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Iglesias Hernangómez, Teresa (Hospital Universitario Clínico San Carlos (Madrid)) ;
Ramírez-García, Almudena (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Gómez-Estévez, Irene (Universidad Complutense de Madrid) ;
Sanabria-Cabrera, Judith (Plataforma ISCIII de Investigación Clínica) ;
Llop Rius, Roser (Hospital Universitari de Bellvitge) ;
Pedrós, Consuelo (Hospital General Universitario de Valencia) ;
Campodonico, Diana (Hospital Universitario de la Princesa (Madrid)) ;
Jiménez-Jorge, Silvia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
García Luque, Amelia (University of Alcalá (IRYCIS)) ;
Costa-Frossard, Lucienne (Hospital Universitario Ramón y Cajal (Madrid)) ;
Montané Esteva, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aldea-Perona, Ana (Hospital del Mar (Barcelona, Catalunya)) ;
Téllez Lara, Nieves (Hospital Clínico Universitario de Valladolid) ;
Bosch Ferrer, Montserrat (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rodriguez Jiménez, Consuelo (Complejo Hospitalario Universitario e Canarias) ;
Bonilla-Toyos, Elvira (Plataforma ISCIII de Investigación Clínica) ;
Sabín Muñoz, Julia (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Avendaño Sola, Cristina (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Blasco Quilez, María Rosario (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Universitat Autònoma de Barcelona
Severe cases of lymphopenia have been reported during siponimod clinical trials, which may negatively impact its benefit/risk profile. We aimed to evaluate the incidence of lymphopenia following the initiation of siponimod treatment in clinical practice. [...]
2023 - 10.3390/jcm12206471
Journal of clinical medicine, Vol. 12 (october 2023)
|
|
|
8.
|
|
11 p, 992.2 KB |
Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY) : A Randomized Clinical Trial
/
Montalescot, Gilles (Centre Hospitalier Universitaire Pitié-Salpêtriėre) ;
Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Cosyns, Bernard (Universitair Ziekenhuis Brussel) ;
Crijns, Harry J. (Maastricht University Medical Centre) ;
D'Angelo, Armando (Scientific Institute San Raffaele) ;
Drouet, Ludovic (Paris Diderot University) ;
Eberli, Franz R. (Stadtspital Triemli) ;
Lane, Deirdre (University of Liverpool and Liverpool Heart & Chest Hospital) ;
Besse, Bruno (Bristol-Myers Squibb) ;
Chan, Anthony (Pfizer Healthcare Ireland) ;
Vicaut, Eric (Centre Hospitalier Universitaire Lariboisière (AP-HP)) ;
Darius, Harald (Vivantes Neukoelln Medical Center) ;
Universitat Autònoma de Barcelona
Adherence to non-vitamin-K oral anticoagulants (NOACs) may be lower than to vitamin K antagonists because NOACs do not require routine monitoring. We assessed the impact of an educational program on adherence and persistence with apixaban in patients with non-valvular atrial fibrillation (NVAF). [...]
2020 - 10.1007/s40256-019-00356-2
American Journal of Cardiovascular Drugs, Vol. 20 Núm. 1 (january 2020) , p. 61-71
|
|
|
9.
|
|
20 p, 1.2 MB |
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain : Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)
/
Hernández-Cruz, Blanca (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Rosas, José (Hospital Marina Baixa. Servei de Reumatologia) ;
Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ;
Belzunegui, Joaquín (Hospital Universitario Donostia. Servicio de Reumatología) ;
García-Vicuña, Rosario (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Inciarte-Mundo, José (Hospital Clínic i Provincial de Barcelona) ;
Pons, Ana (Hospital Marina Baixa. Servei de Reumatologia) ;
Millán, Ana M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Jeria-Navarro, Sicylle (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Valero, Jesús A. (Hospital Universitario Donostia. Servicio de Reumatología) ;
García-Castañeda, Noelia (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Valero Martínez, Cristina (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Llorente Cubas, Irene (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Calvo, Alberto (Hospital Universitario de La Princesa. Servicio de Reumatología. IIS-IP) ;
Díaz-Cerezo, Silvia (Lilly Spain. Medical Department) ;
Núñez, Mercedes (Lilly Spain. Medical Department)
Introduction: Baricitinib is an oral Janus kinase (JAK)1/JAK2 inhibitor approved to treat rheumatoid arthritis (RA). This study aimed to investigate patients' characteristics, prescription patterns, effectiveness, and treatment persistence in patients receiving baricitinib in real-world practice in Spain. [...]
2022 - 10.1007/s40744-021-00423-8
Rheumatology and Therapy, Vol. 9 Núm. 2 (april 2022) , p. 589-608
|
|
|
10.
|
|
15 p, 707.7 KB |
Effectiveness of Acceptance and Commitment Therapy (ACT) for the Management of Postsurgical Pain : Study Protocol of a Randomized Controlled Trial (SPINE-ACT Study)
/
Castaño Asins, Juan Ramon (Hospital del Mar (Barcelona, Catalunya)) ;
Sanabria-Mazo, Juan P.. (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Luciano, Juan V (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Barceló-Soler, Alberto (Instituto de Investigación Sanitaria de Aragón) ;
Martín-López, Luis M. (Hospital del Mar (Barcelona, Catalunya)) ;
Arco-Churruca, Alejandro Del (Hospital del Mar (Barcelona, Catalunya)) ;
Lafuente-Baraza, Jesús (Hospital del Mar (Barcelona, Catalunya)) ;
Bulbena Vilarrasa, Antonio (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Pérez Solà, Víctor (Hospital del Mar (Barcelona, Catalunya)) ;
Montes-Pérez, Antonio (Hospital del Mar (Barcelona, Catalunya))
Research on the use of Acceptance and Commitment Therapy (ACT) for patients with degenerative lumbar pathology awaiting surgery are limited. However, there is evidence to suggest that this psychological therapy may be effective in improving pain interference, anxiety, depression, and quality of life. [...]
2023 - 10.3390/jcm12124066
Journal of clinical medicine, Vol. 12 Núm. 12 (2023) , p. 4066-15
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
